U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07326722) titled 'Delivering tAN to Reduce HMB: The LUNA Study' on Jan. 06.
Brief Summary: The LUNA study is a prospective, randomized, double-blind, sham-controlled, decentralized clinical trial in participants with heavy menstrual bleeding of no known structural cause. The study includes two age-based cohorts: adolescents aged 14-21 and adults aged 22-45. Participants in both cohorts will be randomized to receive transcutaneous auricular neurostimulation (tAN), which targets the auricular branch of the vagus nerve (ABVN) and the auriculotemporal nerve (ATN), or sham stimulation. Participants will be enrolled into the study over the course of five co...